RxDoctor Payments Data

Lauren Herr, NP

Registered Nurse · Evansville, INNPI 1407570864

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,366, more than ten times the $21 reported in 2023. Among registered nurse clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,742in general payments, 2019–2025

Across 119 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$295
  • AbbVie$245
  • Lundbeck LLC$230
  • Axsome Therapeutics, Inc.$223
  • Alkermes, Inc.$185
  • Otsuka America Pharmaceutical, Inc.$98
  • plus $466 from 15 others

What the payments were for

  • Food & beverage$1,742100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,742 in reported general payments places this provider in the 90th percentile of 63 registered nurse providers in Indiana.

See all registered nurse providers in Indiana

Medicare billing

Part B allowed, 2024
$6,686
Medicare patients
11
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl32$40,128
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl37$3,254
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$1,725
Quetiapine Fumarate ErQuetiapine Fumarate16$1,453
Celecoxib14$825
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$547
Gabapentin35$369
Esomeprazole Magnesium12$368
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$363
Pregabalin15$290
Albuterol Sulfate HfaAlbuterol Sulfate17$212
Topiramate19$105
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$88
Rosuvastatin Calcium22$85
Lisinopril25$77

Paid to pharmacies, not to this prescriber.

Other registered nurse in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →